Work

Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohort

Year: 2025

Type: article

Study design: Observational Study

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2025.2470783

Authors: Marisa L. Kometas, Fieke W. Hoff, Jonathan Hyak, Vivian Irizarry-Gatell, Alejandro Marinos Velarde, Clayton Jackson, Julia Anderson, Fatma Neslihan Kalkan, Praveen Ramakrishnan Geethakumari, Julio Alvarenga Thiebaud, Weina Chen, Olga K. Weinberg, Miguel D. Cantu, Robert H. Collins, Stephen S. Chung, Yazan F. Madanat

Institutions: The University of Texas Southwestern Medical Center, Harold C. Simmons Comprehensive Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4408213370

FWCI: 1.304

Cites: 22

Cited by: 2

Related to: 10